NovaBay Pharmaceuticals, Inc.
NBY
$0.60
$0.000.00%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.66M | -7.22M | -10.12M | -10.66M | -11.12M |
| Total Depreciation and Amortization | 424.00K | 465.00K | 465.00K | 465.00K | 439.00K |
| Total Amortization of Deferred Charges | 485.00K | 874.00K | 1.44M | 1.96M | 2.11M |
| Total Other Non-Cash Items | 882.00K | 1.95M | 4.37M | 5.10M | 5.08M |
| Change in Net Operating Assets | 682.00K | -386.00K | -325.00K | 674.00K | -237.00K |
| Cash from Operations | 6.13M | -4.32M | -4.16M | -2.47M | -3.73M |
| Capital Expenditure | -4.00K | -6.00K | -9.00K | -8.00K | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.00K | -6.00K | -9.00K | -8.00K | -8.00K |
| Total Debt Issued | 500.00K | 500.00K | 0.00 | 0.00 | 3.00M |
| Total Debt Repaid | -1.92M | -1.99M | -2.69M | -2.48M | -2.05M |
| Issuance of Common Stock | 3.72M | 3.11M | 3.67M | 791.00K | 565.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.91M | -115.00K | -2.00K | -2.00K | -200.00K |
| Cash from Financing | 389.00K | 1.50M | 974.00K | -1.69M | 1.31M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 126.00K | 126.00K | 590.00K | 313.00K | 297.00K |
| Net Change in Cash | 6.65M | -2.70M | -2.61M | -3.85M | -2.13M |